Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

America’s Fertility Rate Just Hit a Record Low — and the Numbers Are Getting Harder to Ignore

by Team Lumida
April 10, 2026
in Health and Longevity
Reading Time: 3 mins read
A A
0
America’s Fertility Rate Just Hit a Record Low — and the Numbers Are Getting Harder to Ignore
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • The U.S. general fertility rate fell to a record low of 53.1 births per 1,000 women ages 15–44 in 2025, according to provisional CDC data — continuing a decline that began in 2007 and has now persisted through six straight years of flat births (~3.6 million annually)
  • The total fertility rate — the average number of children a woman would have over her lifetime at current rates — dropped to 1.57 in 2025, well below the 2.1 replacement level; the U.S. population will eventually shrink without sustained immigration if this trend continues
  • For the first time in U.S. history, birthrates for women in their late 30s exceeded those for women in their early 20s — a structural shift reflecting delayed parenthood driven by financial uncertainty, relationship instability, and political climate concerns
  • The teen birthrate fell 7% in 2025, extending a decades-long decline; since 2007, the birthrate for 15–19-year-olds has fallen 72%, while births over deaths now produce only a half-million net surplus annually — a surplus Census projects will disappear within a decade

What Happened?

New federal data from the CDC shows that America’s fertility rate fell to a record low in 2025 for the sixth consecutive year of flat total births. The general fertility rate — births per 1,000 women ages 15 to 44 — reached 53.1, its lowest point on record. The total fertility rate dropped to 1.57 births per woman, a WSJ calculation shows, significantly below the 2.1 replacement level required for a population to sustain itself without immigration. A historic milestone was crossed in 2025: for the first time, birthrates for women in their late 30s exceeded those of women in their early 20s, reflecting the long-running shift toward delayed parenthood across generations of American women.

Why It Matters?

The fertility decline is not merely a demographic abstraction — it has direct implications for the U.S. economy, retirement systems, and the labor force over the next two to three decades. Flat births and a rising number of deaths are already shrinking the natural population surplus: the U.S. recorded just over 500,000 more births than deaths in 2025. Census Bureau and CBO projections suggest this surplus will disappear within the next decade. After that, population growth — and with it, the labor force, tax base, and economic dynamism that underpin Social Security and Medicare — will depend entirely on immigration. Demographers note that many women still want children but are waiting until financial and relational conditions feel stable enough, suggesting the gap between desired and actual fertility is structural and policy-amenable, not purely cultural.

What’s Next?

The U.S. fertility rate, while at a record low, remains higher than in many other developed nations — the UN estimates more than half of all countries are already below replacement level globally. But the gap is narrowing, and the U.S. no longer has a meaningful demographic edge over peers. Policy levers that other countries have tried — paid family leave, childcare subsidies, child tax credits — have produced mixed results in shifting fertility rates. The more immediate policy question is immigration: the same restrictionist impulses that have driven recent U.S. immigration enforcement could, if sustained, eliminate the demographic safety valve just as natural population growth runs out. How Washington navigates that tension over the next decade may be one of the most consequential long-run policy choices the country faces.

Source: The Wall Street Journal

Previous Post

Anthropic’s New AI Model Is So Dangerous Bessent and Powell Called an Emergency Meeting With Bank CEOs

Next Post

The ‘Busan Freeze’: How Trump Quietly Abandoned His Tough-on-China Playbook

Recommended For You

Employer Healthcare Costs Projected to Rise 9.5% in 2027 — Fourth Consecutive Year of Near-Double-Digit Increases

by Team Lumida
13 hours ago
doctor holding red stethoscope

Average healthcare costs are projected to reach more than $19,000 per employee in 2027, a 9.5% year-over-year increase, according to Aon. This marks the fourth consecutive year of...

Read more

US Alcohol Consumption Holds at Historic Low as Majority of Americans Now Say Drinking Is Bad for Health

by Team Lumida
2 weeks ago
clear drinking glass with ice cubes

A Gallup poll of 1,200 adults finds 54% of Americans consume alcohol — matching last year's historic low and halting three consecutive annual declines — while 51% now...

Read more

Big Food’s GLP-1 Reckoning: Conagra, Kraft, and Packaged-Food Giants Reformulate for the Not-So-Hungry

by Team Lumida
2 weeks ago
pasta with red sauce on white ceramic round plate

As GLP-1 weight-loss drugs suppress appetite across millions of households, packaged-food companies are retooling recipes, portion sizes, and sensory profiles to win over consumers who eat less but...

Read more

Novo Nordisk Tests Low-Dose Wegovy Pills as Most Patients Already Stick to Smallest Doses

by Team Lumida
2 weeks ago
Novo Nordisk Q2 2024 Earnings Highlights

Novo Nordisk has launched a 450-person trial to determine the minimum effective dose of its oral Wegovy pill — a clinically significant shift given that more than two-thirds...

Read more

4 in 5 Americans Say Healthcare Costs Are the Nation’s Top Health Problem — and Nobody Agrees on Who Should Fix It

by Team Lumida
2 weeks ago
doctor holding red stethoscope

A Commonwealth Fund survey of 25,873 adults finds near-universal alarm over health insurance premiums and out-of-pocket costs, even as ACA marketplace premiums surge 58% in 2026 and nearly...

Read more

Wealthy, Healthy, and Ready to Spend: Baby Boomers Are Driving a Global Travel Boom the Industry Is Racing to Serve

by Team Lumida
2 weeks ago
couple kissing on the road during daytime

Baby boomers — flush with retirement savings and in better health than previous generations — are fueling a high-end travel surge, with the industry responding with private-plane tours,...

Read more

385 Million Patient Records Breached and Counting — DentaQuest’s 15M-Person Hack Leads a New Wave of Healthcare Cybersecurity Disasters

by Team Lumida
3 weeks ago
person sitting while using laptop computer and green stethoscope near

The updated Healthcare Dive breach tracker reveals a sector in crisis: DentaQuest's 15M breach in 2026, Conduent's 62M in 2025, and Change Healthcare's record 192.7M in 2024.

Read more

Healthcare Stocks Are Now an Implicit AI Short — Semiconductors and Pharma Have Flipped to Negative Correlation

by Team Lumida
3 weeks ago
turned on monitoring screen

A structural shift is underway in equity markets: the VanEck Semiconductor ETF and the State Street Health Care ETF have moved into negative correlation, meaning healthcare has effectively...

Read more

Patients Are Using AI to Interpret Their Medical Test Results Before Seeing Doctors — And Doctors Are Struggling to Untangle the Errors

by Team Lumida
4 weeks ago
doctor holding red stethoscope

Roughly a third of American adults now consult AI for health advice, and the majority view test results online before speaking with a doctor — a trend accelerated...

Read more

Novo Nordisk’s $10 Billion Cardiovascular Bet Fails — Ziltivekimab Misses Heart Attack and Stroke Endpoint, Stock Drops 10.5%

by Team Lumida
1 month ago
Novo Nordisk Q2 2024 Earnings Highlights

Novo Nordisk's experimental drug ziltivekimab — a monthly IL-6 inhibitor injection targeting cardiovascular disease, chronic kidney disease, and inflammation in a market Jefferies estimates at $10B+ annually —...

Read more
Next Post
China’s Bold Economic Moves: What You Need to Know Now

The 'Busan Freeze': How Trump Quietly Abandoned His Tough-on-China Playbook

White House, Washington DC

White House Sent Staff-Wide Email Warning Against Insider Trading on Iran War Bets

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

How Nvidia’s AI Chips are Secretly Making Their Way to China

China Urges Firms to Avoid Using Nvidia’s H20 AI Chips Amid Security and Domestic Industry Push

August 12, 2025
A close up of a cell phone with a keyboard

DeepSeek’s Liang Wenfeng Is Now Worth $36 Billion — Richer Than Dario Amodei and Greg Brockman Combined

July 14, 2026
Apollo’s Warning Shot: Private Markets May Be Marking Risk Too Lightly

Apollo’s Warning Shot: Private Markets May Be Marking Risk Too Lightly

March 16, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018